Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,128 public trials 2,031 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

NCT01966367

Conditions: Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndromes, Amegakaryocytic Thrombocytopenia, +65 more
Locations: Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University New York, United States

View Trial Details

Active, not recruiting

Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia

NCT02157324

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Research Site Columbus, Ohio, United States

Research Site Hermitage, Tennessee, United States

Research Site Fort Worth, Texas, United States

View Trial Details

Active, not recruiting

Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

NCT04892667

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +19 more
Locations: Cardiology department Paris, France

View Trial Details

Active, not recruiting

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

NCT02790515

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +32 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, not recruiting

A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02734771

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Active, not recruiting

Health Surveillance at University of Applied Science Hamburg (HAW)

NCT07089914

Conditions: Anxiety, Anxiety Acute, Anxiety Depression, +24 more
Locations: Hamburg University of Applied Sciences/Hochschule für Angewandte Wissenschaften Hamburg (HAW Hamburg) Hamburg, Germany

View Trial Details

Active, not recruiting

CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma

NCT03684889

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, not recruiting

A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan

NCT05286229

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: National Cancer Center Hospital East /ID# 240943 Kashiwa-shi, Chiba, Japan

Hokkaido University Hospital /ID# 242672 Sapporo, Hokkaido, Japan

Kanazawa University Hospital /ID# 240948 Kanazawa, Ishikawa-ken, Japan

Duplicate_Okayama Medical Center /ID# 240949 Okayama, Okayama-ken, Japan

View Trial Details

Active, not recruiting

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

NCT02899052

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: University of Alabama at Birmingham - Main /ID# 151405 Birmingham, Alabama, United States

University of Arkansas for Medical Sciences /ID# 151399 Little Rock, Arkansas, United States

Memorial Healthcare System /ID# 224862 Hollywood, Florida, United States

Winship Cancer Institute of Emory University /ID# 161710 Atlanta, Georgia, United States

View all 32 locations

View Trial Details

Active, not recruiting

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

NCT00379041

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Not specified

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions